AAM
TMO icon

Ardevora Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Ardevora Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-95,714
Closed -$49.9M – 129
2023
Q2 		$49.9M Sell
95,714
-29,185
-23% -$15.7M 1.21% 27
2023
Q1 		$72M Buy
124,899
+8,500
+7% +$4.79M 1.29% 27
2022
Q4 		$64.1M Buy
116,399
+27,863
+31% +$14.8M 1.09% 32
2022
Q3 		$44.9M Sell
88,536
-11,200
-11% -$6.27M 0.81% 59
2022
Q2 		$54.2M Sell
99,736
-3,700
-4% -$2.04M 0.89% 48
2022
Q1 		$61.1M Sell
103,436
-6,308
-6% -$3.62M 0.8% 70
2021
Q4 		$73.2M Sell
109,744
-6,800
-6% -$4.25M 0.78% 77
2021
Q3 		$66.6M Sell
116,544
-16,400
-12% -$9M 0.84% 66
2021
Q2 		$67.1M Buy
132,944
+37,135
+39% +$17.5M 0.85% 75
2021
Q1 		$43.7M Buy
95,809
+500
+0.5% +$239K 0.65% 110
2020
Q4 		$44.4M Sell
95,309
-21,800
-19% -$10.2M 0.69% 111
2020
Q3 		$51.7M Sell
117,109
-700
-0.6% -$289K 0.95% 47
2020
Q2 		$42.7M Sell
117,809
-11,563
-9% -$3.88M 0.84% 85
2020
Q1 		$36.7M Sell
129,372
-13,951
-10% -$4.4M 0.97% 56
2019
Q4 		$46.6M Buy
143,323
+25,300
+21% +$7.67M 1.05% 57
2019
Q3 		$34.4M Buy
118,023
+831
+0.7% +$238K 0.96% 66
2019
Q2 		$34.4M Buy
117,192
+1,400
+1% +$386K 0.84% 76
2019
Q1 		$31.7M Sell
115,792
-3,600
-3% -$896K 0.83% 77
2018
Q4 		$26.7M Sell
119,392
-400
-0.3% -$93.8K 0.8% 87
2018
Q3 		$29.2M Sell
119,792
-11,000
-8% -$2.53M 0.81% 74
2018
Q2 		$27.1M Sell
130,792
-26,608
-17% -$5.65M 0.76% 93
2018
Q1 		$32.5M Sell
157,400
-2,400
-2% -$504K 0.97% 61
2017
Q4 		$30.3M Buy
+159,800
New +$30.6M 0.91% 70

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ardevora Asset Management's TMO Position: Q3 2023 in Review

Ardevora Asset Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 95,714 shares — an estimated $49.9M sold.

Ardevora Asset Management first reported a position in TMO in Q4 2017 and held it in 23 quarters. The position peaked at $73.2M in Q4 2021. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Ardevora Asset Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Ardevora Asset Management sold 95,714 Thermo Fisher Scientific shares in Q3 2023, an estimated $49.9M.
  • Ardevora Asset Management first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 23 quarters.
  • Ardevora Asset Management's Thermo Fisher Scientific position peaked at $73.2M in Q4 2021.
  • 2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Ardevora Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.